Dietary Intake of Acrylamide and Risk of Breast, Endometrial,
and Ovarian Cancers: A Systematic Review and Dose-Response
Meta-analysis

J 2020

Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis

ADANI, Giorgia; Tommaso FILIPPINI; Lauren A. WISE; Thorhallur I. HALLDORSSON; Luděk BLÁHA et al.

Základní údaje

Originální název

Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis

Autoři

ADANI, Giorgia; Tommaso FILIPPINI; Lauren A. WISE; Thorhallur I. HALLDORSSON; Luděk BLÁHA a Marco VINCETI

Vydání

Cancer Epidemiology, Biomarkers & Prevention, Philadelphia, American Association for Cancer Research, 2020, 1055-9965

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.254

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/20:00116472

Organizační jednotka

Přírodovědecká fakulta

Klíčová slova anglicky

NONSMOKING POSTMENOPAUSAL WOMEN; HEMOGLOBIN ADDUCT LEVELS; PROSPECTIVE COHORT; DRINKING-WATER; B6C3F(1) MICE; AIR-POLLUTION; F344/N RATS; GLYCIDAMIDE; EXPOSURE; CARCINOGENICITY

Štítky

143180, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 30. 10. 2020 16:23, Mgr. Marie Novosadová Šípková, DiS.

Anotace

V originále

Acrylamide is a probable human carcinogen. Aside from occupational exposures and smoking, diet is the main source of exposure in humans. We performed a systematic review of the association between estimated dietary intake of acrylamide and risk of female breast, endometrial, and ovarian cancers in nonexperimental studies published through February 25, 2020, and conducted a dose-response meta-analysis. We identified 18 papers covering 10 different study populations: 16 cohort and two case-control studies. Acrylamide intake was associated with a slightly increased risk of ovarian cancer, particularly among never smokers. For endometrial cancer, risk was highest at intermediate levels of exposure, whereas the association was more linear and positive among never smokers. For breast cancer, we found evidence of a null or inverse relation between exposure and risk, particularly among never smokers and postmenopausal women. In a subgroup analysis limited to premenopausal women, breast cancer risk increased linearly with acrylamide intake starting at 20 mg/day of intake. High acrylamide intake was associated with increased risks of ovarian and endometrial cancers in a relatively linear manner, especially among never smokers. Conversely, little association was observed between acrylamide intake and breast cancer risk, with the exception of premenopausal women.

Návaznosti

733032, interní kód MU

Název: European Human Biomonitoring Initiative (Akronym: HBM4EU)

Investor: Evropská unie, European Human Biomonitoring Initiative, Health, demographic change and wellbeing (Societal Challenges)

Citovat

ADANI, Giorgia; Tommaso FILIPPINI; Lauren A. WISE; Thorhallur I. HALLDORSSON; Luděk BLÁHA a Marco VINCETI. Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention. Philadelphia: American Association for Cancer Research, 2020, roč. 29, č. 6, s. 1095-1106. ISSN 1055-9965. Dostupné z: https://doi.org/10.1158/1055-9965.EPI-19-1628.

@article{1680257,
   author = {Adani, Giorgia and Filippini, Tommaso and Wise, Lauren A. and Halldorsson, Thorhallur I. and Bláha, Luděk and Vinceti, Marco},
   article_location = {Philadelphia},
   article_number = {6},
   doi = {https://doi.org/10.1158/1055-9965.EPI-19-1628},
   keywords = {NONSMOKING POSTMENOPAUSAL WOMEN; HEMOGLOBIN ADDUCT LEVELS; PROSPECTIVE COHORT; DRINKING-WATER; B6C3F(1) MICE; AIR-POLLUTION; F344/N RATS; GLYCIDAMIDE; EXPOSURE; CARCINOGENICITY},
   language = {eng},
   issn = {1055-9965},
   journal = {Cancer Epidemiology, Biomarkers & Prevention},
   title = {Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis},
   url = {https://cebp.aacrjournals.org/content/29/6/1095},
   volume = {29},
   year = {2020}
}

TY  - JOUR
ID  - 1680257
AU  - Adani, Giorgia - Filippini, Tommaso - Wise, Lauren A. - Halldorsson, Thorhallur I. - Bláha, Luděk - Vinceti, Marco
PY  - 2020
TI  - Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis
JF  - Cancer Epidemiology, Biomarkers & Prevention
VL  - 29
IS  - 6
SP  - 1095-1106
EP  - 1095-1106
PB  - American Association for Cancer Research
SN  - 10559965
KW  - NONSMOKING POSTMENOPAUSAL WOMEN
KW  - HEMOGLOBIN ADDUCT LEVELS
KW  - PROSPECTIVE COHORT
KW  - DRINKING-WATER
KW  - B6C3F(1) MICE
KW  - AIR-POLLUTION
KW  - F344/N RATS
KW  - GLYCIDAMIDE
KW  - EXPOSURE
KW  - CARCINOGENICITY
UR  - https://cebp.aacrjournals.org/content/29/6/1095
L2  - https://cebp.aacrjournals.org/content/29/6/1095
N2  - Acrylamide is a probable human carcinogen. Aside from occupational exposures and smoking, diet is the main source of exposure in humans. We performed a systematic review of the association between estimated dietary intake of acrylamide and risk of female breast, endometrial, and ovarian cancers in nonexperimental studies published through February 25, 2020, and conducted a dose-response meta-analysis. We identified 18 papers covering 10 different study populations: 16 cohort and two case-control studies. Acrylamide intake was associated with a slightly increased risk of ovarian cancer, particularly among never smokers. For endometrial cancer, risk was highest at intermediate levels of exposure, whereas the association was more linear and positive among never smokers. For breast cancer, we found evidence of a null or inverse relation between exposure and risk, particularly among never smokers and postmenopausal women. In a subgroup analysis limited to premenopausal women, breast cancer risk increased linearly with acrylamide intake starting at 20 mg/day of intake. High acrylamide intake was associated with increased risks of ovarian and endometrial cancers in a relatively linear manner, especially among never smokers. Conversely, little association was observed between acrylamide intake and breast cancer risk, with the exception of premenopausal women.
ER  -

ADANI, Giorgia; Tommaso FILIPPINI; Lauren A. WISE; Thorhallur I. HALLDORSSON; Luděk BLÁHA a Marco VINCETI. Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis. \textit{Cancer Epidemiology, Biomarkers \&{} Prevention}. Philadelphia: American Association for Cancer Research, 2020, roč.~29, č.~6, s.~1095-1106. ISSN~1055-9965. Dostupné z: https://doi.org/10.1158/1055-9965.EPI-19-1628.

Přehled o publikaci